SubQSA

A Single-arm, Open-label, Phase 2 Study Evaluating Subcutaneous Administration of Isatuximab, Administered by an On Body Delivery System, in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma (RRMM)

Near Add Your Location

Sorting 20 by

Memorial Sloan Kettering Cancer Center
New York, NY
Fully Open
  • Accepting patients
  • Show Principal Investigator
Michigan Hematology and Oncology Consultants
Corewell Health
Dearborn, MI
  • Accepting patients
Prisma Health Cancer Institute - Eastside
Eastside
Greenville, SC
  • Accepting patients
SSM Health Cancer Care
Madison, WI
  • Accepting patients
Hematology Oncology Consultants
William Beaumont University Hospital
Royal Oak, MI
  • Accepting patients
Millennium Oncology Research Clinic
Pembroke Pines, FL
  • Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 850-0650

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.